Veana Therapeutics LLC - OR Washington, Portland 97229

Veana Therapeutics LLC entered the industry of Commercial Biotechnical Research in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Emmanuel Akporiaye by calling (503) 292-4065 during business hours. You can also write to the business’ Single Location at 8417 Nw Adams St, Portland, Oregon OR 97229. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Veana Therapeutics LLC
Representative: Emmanuel Akporiaye
Place of Business: 8417 Nw Adams St, Portland, OR 97229
Contact Number: (503) 292-4065
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2013
Income/Year: $50.000 to $99.999
Laborers: 1 to 4
Share This Company:

Veana Therapeutics LLC is a company operating from Washington, Oregon providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Veana Therapeutics LLC has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Emmanuel Akporiaye at (503) 292-4065 for related queries, or to locate its Single Location using the coordinates 45.532214,-122.764156.

The Single Location can also be found at the street address 8417 Nw Adams St in Portland, Oregon 97229 and can be engaged online through the company website at , the company Twitter , and Facebook page .